Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
06/2012
06/07/2012US20120141565 Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications
06/07/2012US20120141564 Compositions and methods of treating inflammation
06/07/2012US20120141514 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/07/2012US20120141499 Specific binding agents of human angiopoietin-2
06/07/2012US20120141452 Targeted Therapeutic Proteins
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141446 Oral Nutritional Supplement Delivery System
06/07/2012US20120141445 Nutrition for improving muscle strength in elderly
06/07/2012US20120141436 Compositions and methods for promoting beta cell maturity
06/07/2012US20120141416 Multimeric peptide conjugates and uses thereof
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
06/07/2012US20120138506 Methods of treatment and pharmaceutical composition
06/07/2012CA2819648A1 Substituted purine and 7-deazapurine compounds
06/07/2012CA2819508A1 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012CA2819504A1 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
06/07/2012CA2819400A1 Bicyclic compound
06/07/2012CA2819262A1 Increasing drug bioavailability in naltrexone therapy
06/07/2012CA2819251A1 Treatment of obesity using non-daily administration of 6 - 0 - (4 - dimethylaminoethoxy) cinnamoyl fumagillol
06/07/2012CA2817773A1 Methods for increasing intracellular activity of hsp70
06/07/2012CA2804129A1 Manufacturing method for dried earthworm powder
06/06/2012EP2460806A1 Nitrogen-containing spiro-ring compound and medicinal use of same
06/06/2012EP2460787A1 Amide compounds and their use as PGE2 antagonists.
06/06/2012EP2460527A1 Pharmaceutical composition for treating a metabolic syndrome
06/06/2012EP2460520A1 Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy
06/06/2012EP2460517A1 Reducing risk of type 2 diabetes (T2D)
06/06/2012EP2459581A2 Liver x receptor agonists
06/06/2012EP2459568A1 Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/06/2012EP2459554A2 Substituted benzamide derivatives as glucokinase (gk) activators
06/06/2012EP2459548A1 Tetrahydroquinoxaline urea derivatives, preparation thereof, and therapeutic use thereof
06/06/2012EP2459544A2 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents
06/06/2012EP2459541A1 Dihydropyrimidone amides as p2x7 modulators
06/06/2012EP2459228A1 Prodrugs comprising an insulin linker conjugate
06/06/2012EP2459208A2 Therapeutic agents for reducing parathyroid hormone levels
06/06/2012EP2459207A2 Pharmaceutical composition for treating medical conditions and a method for treating alimentary disorders and related diseases
06/06/2012EP2459189A1 Fatty acids as anti-inflammatory agents
06/06/2012EP2240155B1 Devices, formulations, and methods for delivery of multiple beneficial agents
06/06/2012EP2001842B1 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
06/06/2012EP1909912B1 Use of collismycin A as oxidative stress inhibitor
06/06/2012EP1661579B1 Method for treating systemic bacterial infection associated with changes of qualitative and/or quantitative composition of blood extracellular dna
06/06/2012EP1548024B1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
06/06/2012DE102010053567A1 Formulation and device, useful for local increase of efficiency and practical use of preventive or mitigation measure against hypoglycemia, comprise a sprayable formulation comprising a mixture of a sugar and a sodium ion releasing salt
06/06/2012CN1935839B Analogues of GLP-1
06/06/2012CN1561343B Soluble T cell receptor
06/06/2012CN102485261A Medicine for treating diabetes and preparation method thereof
06/06/2012CN102485259A Preparation method and application of ginseng fruit medicinal dispersing tablets and buccal tablets
06/06/2012CN102485235A Method for extraction and preparation of ganoderma lucidum allpmelanin and use of the ganoderma lucidum allpmelanin
06/06/2012CN101953910B Coptis alkaloid and ferulic acid compound with glucose-lowering effect
06/06/2012CN101940785B Hydrogen sulfide-producing enzyme preparation and use thereof
06/06/2012CN101920019B Hydrophilic polymer-puerarin specific conjugated non-hemolytic conjugate
06/06/2012CN101890073B Chinese medicinal composition for preventing and treating hyperlipaemia and fatty liver and preparation method thereof
06/06/2012CN101862274B Skincare product compound containing folic acid and preparation method thereof
06/06/2012CN101829151B Preparation method of fly micromolecular active substance with blood fat-reducing function
06/06/2012CN101775026B Spiro alkaloid compound, medicinal composition comprising same and preparation method and application thereof
06/06/2012CN101744790B Method for preparing stable-type vitamin A microcapsules continuously
06/06/2012CN101694487B Screening method, extracting method, content measuring method and application of glycyrrhisoflavone in liquorice
06/06/2012CN101659706B Method for purifying and separating X-fraction polysaccharide from fruit bodies or mycelia of polyporus frondosus
06/06/2012CN101574423B Application of medicine combination in preparing medicament for reducing insulin resistance
06/06/2012CN101564163B Food for reducing blood sugar and blood fat and preparation method thereof
06/06/2012CN101478960B Compounds A-R-X for the manufacture of pharmaceutical preparations
06/06/2012CN101300010B Pharmaceutical preparation having excellent photostability
06/06/2012CN101189210B Sulfonamide derivatives useful as liver carnitine palmitoyl transferase (L-CPTl) inhibitors
06/05/2012US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
06/05/2012US8193195 Polymorphic forms of 1-'4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride
06/05/2012US8193166 Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
06/05/2012US8192769 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
06/05/2012US8192753 pH-sensitive cationic lipids, and liposomes and nanocapsules containing the same
06/05/2012US8192735 Method for modulating appetite
06/05/2012CA2681809C Imidazolidinone derivatives
06/05/2012CA2590763C The healthy and functional foods for the obesity patients using purple-colored potato
06/05/2012CA2557275C Bicyclo derivative
06/05/2012CA2529443C Pyrido[2,1-a]-isoquinoline derivatives as dpp-iv inhibitors
06/05/2012CA2520740C Process for the preparation of amorphous calcium salt of atorvastatin
06/05/2012CA2519787C Methods of treating diabetes by blocking vegf-mediated activity
06/05/2012CA2508024C Novel aromatic fluoroglycoside derivatives, pharmaceutical products containing said compounds and the use thereof
06/05/2012CA2446439C .delta.4-desaturase genes and uses thereof
06/05/2012CA2435375C Mammalian tumor susceptibility gene products and their uses
06/05/2012CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta
05/2012
05/31/2012WO2012070905A2 Mollusk extract for preventing or treating rare and intractable diseases of the human body
05/31/2012WO2012070702A1 Composition containing orlistat and chitosan and preparation method thereof
05/31/2012WO2012070656A1 Process for production of hydroxystilbene derivative having physiological activity
05/31/2012WO2012070649A1 Highly-soluble pyrroloquinoline quinone salt and method for producing same
05/31/2012WO2012070621A1 Use of age-specific aptamer for treating renal disease
05/31/2012WO2012070554A1 Peptide
05/31/2012WO2012070114A1 Sulfamide derivative having npy y5 receptor antagonism
05/31/2012WO2012070043A1 Method and composition for weight-gain management
05/31/2012WO2012069948A1 4- (5-cyano-pyrazol-1-yl) -piperidine derivatives as gpr 119 modulators
05/31/2012WO2012069917A1 Bicyclic gpr119 modulators
05/31/2012WO2012069419A1 Calcium-sensing receptor-active compounds
05/31/2012WO2012069394A1 Multicomponent system of rosuvastatin calcium salt and sorbitol
05/31/2012WO2012047628A3 Methods of managing blood sugar levels and compositions related thereto
05/31/2012WO2012033378A3 Composition comprising cudrania tricuspidata and coix lachryma-jobi having an obesity-suppressing activity and blood-sugar lowering effect, and a use therefor
05/31/2012WO2012027601A9 Methods targeting mir-33 micrornas for regulating lipid metabolism
05/31/2012WO2012020956A3 Production method for a functional grain using red-yeast rice
05/31/2012WO2012011752A3 Novel long-acting glucagon conjugate and pharmaceutical composition comprising the same for the prevention and treatment of obesity
05/31/2012WO2012011707A3 Substituted pyridinone derivatives and methods for manufacturing the same
05/31/2012WO2011140132A9 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
05/31/2012US20120136058 Method For Increasing The Solubility Of Methionine By Mineral Addition And Acid Treatment
1 ... 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 ... 1298